Feb 26, 2026 07:30AM
Jan 5, 2026 07:00AM
Jan 5, 2026 07:00AM
Dec 4, 2025 06:35AM
Dec 4, 2025 06:35AM
Nov 6, 2025 07:30AM
May 9, 2022 08:30AM Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results
Mar 31, 2022 08:00AM
Mar 16, 2022 09:26AM
Mar 15, 2022 05:51PM
Jan 25, 2022 08:04AM
Jan 25, 2022 08:00AM
Sep 28, 2021 04:03PM
Sep 28, 2021 04:01PM FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency
Aug 5, 2021 08:00AM
Jun 28, 2021 08:08AM
Jun 28, 2021 08:00AM
Mar 4, 2021 08:00AM
Dec 2, 2020 08:03AM
Dec 2, 2020 08:00AM
Aug 18, 2020 04:30PM Softlab9 Target Acquisition CleanGo GreenGo Signs Supply Agreement
Jun 22, 2020 04:05PM
Jun 22, 2020 08:00AM
Jun 19, 2020 11:48AM
Jun 19, 2020 11:45AM
Jun 18, 2020 09:26AM
Jun 18, 2020 09:09AM
Jun 18, 2020 09:00AM Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
Jun 17, 2020 04:03PM
Jun 17, 2020 04:01PM
Jun 15, 2020 08:05AM
Jun 15, 2020 08:00AM
Jun 15, 2020 07:02AM
Jun 15, 2020 07:00AM
Jun 12, 2020 08:00AM Catalyst Biosciences Present at the Raymond James Human Health Innovation Conference
Jun 10, 2020 08:10AM
Jun 10, 2020 08:00AM
Jun 8, 2020 08:00AM
May 11, 2020 08:00AM
Apr 28, 2020 08:06AM
Apr 28, 2020 08:00AM
Apr 6, 2020 08:10AM Catalyst Biosciences (CBIO) Reports Pivotal Phase 3 Study Design for MarzAA in Individuals with Hemophilia A or B with Inhibitors
Apr 6, 2020 08:00AM
Feb 20, 2020 04:05PM
Nov 7, 2019 08:00AM
Aug 1, 2019 08:00AM
Jul 8, 2019 05:55AM
Jul 8, 2019 05:00AM
May 2, 2019 08:00AM Catalyst Biosciences Reports First Quarter 2019 Operating & Financial Results and Provides a Corporate Update
Apr 1, 2019 12:45PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All